Magnus Nordenskjöld mostly deals with Genetics, Molecular biology, Locus, Loss of heterozygosity and Chromosome. Chromosome 22, Allele, Mutation, Chromosome 13 and Genetic linkage are the primary areas of interest in his Genetics study. His Molecular biology research integrates issues from Cell, Carcinogenesis, Complementary DNA and Telomerase, Telomerase reverse transcriptase.
His work carried out in the field of Locus brings together such families of science as Autosome, Deletion mapping, Autosomal dominant trait and Multiple endocrine neoplasia, MEN1. His Loss of heterozygosity research includes elements of Germline mutation, Birt–Hogg–Dubé syndrome, Genotype and Pathology. To a larger extent, he studies Gene with the aim of understanding Chromosome.
Genetics, Gene, Molecular biology, Immunology and Cancer research are his primary areas of study. Chromosome, Locus, Mutation, Chromosome 22 and Karyotype are the subjects of his Genetics studies. The various areas that Magnus Nordenskjöld examines in his Locus study include Genetic marker, Genetic linkage, MEN1 and Allele.
His studies deal with areas such as Complementary DNA and DNA, Cosmid as well as Molecular biology. His research integrates issues of Hemophagocytic lymphohistiocytosis and Internal medicine in his study of Immunology. Pathology is closely connected to Cancer in his research, which is encompassed under the umbrella topic of Cancer research.
His scientific interests lie mostly in Genetics, Gene, Mutation, Phenotype and Immunology. His study in Bioinformatics extends to Genetics with its themes. Magnus Nordenskjöld has included themes like Molecular biology, Autism, Mutant and Copy-number variation in his Mutation study.
His studies in Molecular biology integrate themes in fields like Zebrafish, Morpholino, Molecular genetics, Hypotonia and Sanger sequencing. The study incorporates disciplines such as Brachydactyly, Chronic pain, Platyspondyly and Scoliosis in addition to Phenotype. His Chromosome 21 study which covers Cancer research that intersects with Lymphoma, B cell and Cancer.
His primary areas of investigation include Genetics, Mutation, Gene, Missense mutation and Immunology. His is involved in several facets of Genetics study, as is seen by his studies on Genetic heterogeneity, Exome sequencing, Point mutation, Intellectual disability and Breakpoint. His Mutation study incorporates themes from Phenotype, Molecular biology and Allele.
His research on Phenotype also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern
Eva Enmark;Markku Pelto-Huikko;Markku Pelto-Huikko;Kaj Grandien;Svetlana Lagercrantz.
The Journal of Clinical Endocrinology and Metabolism (1997)
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
Charis Eng;Charis Eng;David Clayton;Isabelle Schuffenecker;Gilbert Lenoir.
JAMA (1996)
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma
Catharina Larsson;Britt Skogseid;Kjell Öberg;Yusuke Nakamura.
Nature (1988)
Cytogenetic analysis by chromosome painting using dop-pcr amplified flow-sorted chromosomes
HÅKan Telenius;HÅKan Telenius;Bruce A. J. Ponder;Alan Tunnacliffe;Adèle H. Pelmear.
Genes, Chromosomes and Cancer (1992)
Clonal Genomic Alterations in Glioma Malignancy Stages
C. David James;Elisabeth Carlbom;Jan P. Dumanski;Marc Hansen.
Cancer Research (1988)
Genetic mapping of a second locus predisposing to hereditary non–polyposis colon cancer
Annika Lindblom;Pia Tannergård;Barbro Werelius;Magnus Nordenskjöld.
Nature Genetics (1993)
Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas
M H Ruttledge;J Sarrazin;S Rangaratnam;C M Phelan.
Nature Genetics (1994)
Birt-Hogg-Dubé syndrome: diagnosis and management
Fred H Menko;Maurice Am van Steensel;Sophie Giraud;Lennart Friis-Hansen.
Lancet Oncology (2009)
Genetic origin of mutations predisposing to retinoblastoma.
Webster K. Cavenee;Marc F. Hansen;Magnus Nordenskjold;Eric Kock.
Science (1985)
Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors
Camilla Bystrom;Catharina Larsson;Carl Blomberg;Kerstin Sandelin.
Proceedings of the National Academy of Sciences of the United States of America (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Karolinska University Hospital
Karolinska Institute
Karolinska University Hospital
University of Bergen
Uppsala University
Karolinska Institute
National University of Singapore
University of Adelaide
University of Washington
Karolinska Institute
Technion – Israel Institute of Technology
McMaster University
The University of Texas at Dallas
National Renewable Energy Laboratory
Zhejiang University
Wellcome Sanger Institute
National Center for Toxicological Research
Agriculture and Agriculture-Food Canada
Washington University in St. Louis
Juntendo University
University of Montreal
Boston Children's Hospital
Spanish National Research Council
Agricultural Research Education And Extention Organization
University of California, San Diego
Georgia State University